Purification and Analysis of Proteinase-resistant Mutants of Recombinant Platelet-derived Growth Factor-BB Exhibiting Improved Biological Activity
Overview
Authors
Affiliations
Recombinant platelet-derived growth factor (PDGF)-BB was expressed and secreted from yeast in order to study the structure-function relationships of this mitogen. A simple purification scheme has been developed which yields greater than 95% pure PDGF-BB. Analysis of this recombinant PDGF-BB shows partial proteolysis after arginine-32. Substitution of this arginine residue, or arginine-28 [a potential KEX2 (lysine-arginine endopeptidase) cleavage site], prevents or reduces cleavage of PDGF-BB respectively. These mutations result in a 5-fold increase in expression levels of PDGF-BB, and the resulting mutant proteins show higher activity in a number of biological assays than the cleaved wildtype PDGF-BB. These data are in accord with previous work by Giese, LaRochelle, May-Siroff, Robbins & Aaronson [(1990) Mol. Cell Biol. 10, 5496-5501] suggesting that the region isoleucine-25-phenylalanine-37 is involved in PDGF-receptor binding.
Engineering growth factors for regenerative medicine applications.
Mitchell A, Briquez P, Hubbell J, Cochran J Acta Biomater. 2015; 30:1-12.
PMID: 26555377 PMC: 6067679. DOI: 10.1016/j.actbio.2015.11.007.
Schilling D, Reid IV J, Hujer A, Morgan D, DeMoll E, Bummer P Biochem J. 1998; 333 ( Pt 3):637-44.
PMID: 9677323 PMC: 1219627. DOI: 10.1042/bj3330637.
Craig S, Clements J, Cook A, Dryden D, Green D, Heremans K Biochem J. 1992; 281 ( Pt 1):67-72.
PMID: 1731769 PMC: 1130641. DOI: 10.1042/bj2810067.